查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1865488

全球睡眠呼吸中止症诊断和治疗设备市场：预测至2032年－按产品类型、技术、分销管道、应用、最终用户和地区分類的分析

Sleep Apnea Diagnostic and Therapeutic Devices Market Forecasts to 2032 - Global Analysis By Product Type (Diagnostic Devices, Therapeutic Devices and Accessories & Consumables), Technology, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，全球睡眠呼吸中止症诊断和治疗设备市场预计到 2025 年将达到 70 亿美元，到 2032 年将达到 133 亿美元，在预测期内的复合年增长率为 9.6%。

睡眠呼吸中止症诊断和治疗设备是用于检测、监测和治疗睡眠呼吸中止症的医疗技术。睡眠呼吸中止症是一种以睡眠期间反覆呼吸中止为特征的疾病。诊断设备，例如睡眠多项生理检查系统、家庭睡眠检测套组和脉动式血氧监测仪系统，可以记录气流、氧浓度和呼吸努力等生理参数，从而识别呼吸中止​​事件。治疗设备，包括持续性呼吸道正压通气（CPAP）设备、双水平气道正压通气（BiPAP）设备、口腔矫正器和自适应伺服呼吸机，有助于在睡眠期间保持气道畅通并稳定呼吸。这些设备在改善睡眠品质、预防併发症和提升整体健康水平方面发挥着重要作用。

睡眠呼吸中止症发生率上升

睡眠呼吸障碍影响全球数百万人，并导致心血管、神经系统和代谢併发症。此平台支援使用CPAP、BiPAP和穿戴式诊断装置进行早期检测、症状监测和治疗遵从性评估。与远端医疗、人工智慧筛检和远端监测的整合提高了服务的可近性和临床疗效。人口老化和高风险族群的增加推动了对扩充性、非侵入性解决方案的需求。这些趋势正在推动睡眠医学和慢性病管理生态系统对此平台的广泛应用。

更高的医疗成本和持续的耗材成本

设备需要初步投资，面罩、导管、过滤器等耗材也需要持续投入，这会对患者的预算造成压力。报销缺口和分散的支付方政策进一步加剧了取得和负担能力的困难。企业在定价模式与临床疗效和病人参与之间保持平衡方面面临挑战。供应商必须提供订阅模式、打包式医疗服务和成本透明的平台，才能提高使用者接受度。这些限制因素持续阻碍着平台在低收入和无保险人口中的普及。

转向居家检测和远端医疗

为了避免诊所候诊时间并提高便利性，患者越来越倾向于居家睡眠测试和线上咨询。平台可连接行动应用程式、云端基础分析和穿戴式感测器，提供即时洞察和个人化治疗。基层医疗、企业健康计划和保险援助计划对扩充性且符合隐私保护要求的解决方案的需求日益增长。供应商提供模组化套件、人工智慧驱动的分诊和结果仪錶盘，以支援混合护理模式。这些趋势正在推动以家庭为中心的数位化睡眠呼吸中止症生态系统的发展。

发展中市场缺乏意识和基础设施

许多地区缺乏训练有素的睡眠专家、诊断实验室和报销机制，难以支持广泛的筛检和治疗。文化偏见、健康素养低下以及数位接取受限进一步抑制了需求和参与。企业在向农村和城乡结合部人口部署可扩展且扩充性的解决方案方面面临挑战。供应商必须透过教育宣传活动、行动优先平台以及对公私合营的投资来扩大其覆盖范围。这些限制因素持续限制着服务不足地区和基础设施有限地区的平台效能。

新冠疫情的感染疾病：

疫情扰乱了全球睡眠诊所的诊断流程和治疗顺从性。封锁措施延误了检查室检查，并减少了呼吸治疗师和睡眠专家的诊疗机会。疫情后的恢復期，睡眠医学领域更重视远距医疗、数位化诊断和病患自我管理。医疗系统和消费者管道对远端监测、人工智慧筛检和家庭治疗的投资激增。政策制定者和临床医生对睡眠健康与免疫力和心理健康之间联繫的认识也在不断提高。这些变化支持对去中心化、数位化睡眠呼吸中止症基础设施进行长期投资。

预计在预测期内，治疗器材领域将占据最大的市场规模。

由于其在治疗睡眠呼吸中止症方面的临床效用、扩充性和广泛应用，预计治疗设备领域将在预测期内占据最大的市场份额。该领域涵盖CPAP、BiPAP和自动调节设备等平台，这些设备有助于呼吸道管理和缓解症状。与加湿器整合、数据追踪和远端监测功能可提高治疗依从性和个人化程度。居家医疗和门诊护理机构对紧凑、静音和便携设备的需求日益增长。供应商提供模组化配置、云端连接和病人参与工具，以支持长期治疗。这些特性巩固了该领域在治疗睡眠呼吸中止症平台的主导地位。

预计在预测期内，复杂性睡眠呼吸中止症细分市场将呈现最高的复合年增长率。

预计在预测期内，复杂睡眠呼吸中止症领域将迎来最高的成长率，这主要得益于诊断和治疗平台在混合型和治疗诱髮型睡眠呼吸中止症病例中的应用。这类患者同时表现出阻塞性和中枢性睡眠呼吸中止模式，需要高阶监测和适应性治疗。相关平台支援多通道诊断、演算法滴定以及跨心臟病学、神经病学和肺病学的综合护理。与人工智慧引擎、穿戴式感测器和云端基础分析的整合提高了诊断的准确性和响应速度。专科诊所和三级医疗中心对扩充性且经过临床检验的解决方案的需求日益增长。这些趋势正在推动复杂睡眠呼吸中止症平台和服务的发展。

占比最大的地区：

由于医疗基础设施、报销体系的进步以及睡眠呼吸中止症技术的临床应用，预计北美将在预测期内占据最大的市场份额。为了满足不断增长的需求，企业和医疗服务提供者正在医院、居家医疗和企业健康计划中部署相关平台。对人工智慧诊断、远端医疗和治疗创新的投资有助于扩充性和个人化。主要供应商、学术机构和政策倡议的参与正在推动生态系统的成熟和普及。各公司正在将其睡眠呼吸中止症策略与慢性病管理、价值医疗和数位健康目标结合。

年复合成长率最高的地区：

预计亚太地区在预测期内将实现最高的复合年增长率，这主要得益于都市化、医疗保健现代化以及人们对睡眠障碍认识的不断提高，这些因素共同推动了该地区的经济发展。中国、印度、日本和韩国等国家正在拓展其在公共卫生、企业健康和消费者管道的平台。政府支持计画正在支持睡眠医学领域的基础设施建设、数位医疗应用和宣传宣传活动。本地医疗服务提供者正在提供经济高效、符合当地文化且以行动端为先的解决方案，以满足当地需求。都市区和近郊市场对扩充性且整体性的睡眠呼吸中止症基础设施的需求日益增长。这些趋势正在推动该地区睡眠呼吸中止症创新和应用的成长。

免费客製化服务

订阅本报告的用户可从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 引言

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 分析方法
  • 分析材料
    • 原始研究资料
    • 二手研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 介绍
  • 司机
  • 抑制因素
  • 市场机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新参与企业的威胁
  • 公司间的竞争

5. 全球睡眠呼吸中止症诊断和治疗设备市场（按产品类型划分）

  • 介绍
  • 诊断设备
  • 治疗设备
  • 配件和耗材

6. 全球睡眠呼吸中止症诊断和治疗设备市场（按技术划分）

  • 介绍
  • 诊断技术
    • 睡眠多项生理检查（PSG）系统
    • 呼吸多导仪
    • 脉动式血氧监测仪系统
    • 活动记录仪
    • 人工智慧睡眠监测
    • 云端基础的数据分析
  • 治疗技术
    • 正压通气（PAP）装置
    • 口腔矫正器
    • ASV (Adaptive Servo-Ventilation)
    • 智慧口罩及配件
    • 加湿器，舒适设备
    • 远端监控和联网治疗系统

7. 全球睡眠呼吸中止症诊断和治疗设备市场（按分销管道划分）

  • 介绍
  • 医院药房
  • 零售药房
  • 线上平台
  • 直销

8. 全球睡眠呼吸中止症诊断和治疗设备市场（按应用划分）

  • 介绍
  • 阻塞型睡眠呼吸中止症（OSA）
  • 中枢性睡眠呼吸中止症（CSA）
  • 复杂性睡眠呼吸中止症
  • 其他用途

9. 全球睡眠呼吸中止症诊断和治疗设备市场（按最终用户划分）

  • 介绍
  • 医院
  • 睡眠诊所
  • 居家医疗
  • 研究和学术机构
  • 其他最终用户

第十章 全球睡眠呼吸中止症诊断与治疗设备市场（按地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併（M&A）
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章：公司简介

  • ResMed Inc.
  • Koninklijke Philips NV
  • Fisher & Paykel Healthcare Corporation Limited
  • Drive DeVilbiss Healthcare LLC
  • Compumedics Limited
  • BMC Medical Co. Ltd.
  • SomnoMed Limited
  • Natus Medical Incorporated
  • Itamar Medical Ltd.
  • Braebon Medical Corporation
  • Curative Medical Inc.
  • Lowenstein Medical Technology GmbH+Co. KG
  • Cadwell Industries Inc.
  • Cleveland Medical Devices Inc.
  • AirAvant Medical Inc.
Product Code: SMRC32186

According to Stratistics MRC, the Global Sleep Apnea Diagnostic and Therapeutic Devices Market is accounted for $7.0 billion in 2025 and is expected to reach $13.3 billion by 2032 growing at a CAGR of 9.6% during the forecast period. Sleep apnea diagnostic and therapeutic devices are medical technologies designed to detect, monitor, and treat sleep apnea-a disorder characterized by repeated interruptions in breathing during sleep. Diagnostic devices, such as polysomnography systems, home sleep testing kits, and oximeters, record physiological parameters like airflow, oxygen levels, and respiratory effort to identify apnea episodes. Therapeutic devices, including continuous positive airway pressure (CPAP) machines, bi-level positive airway pressure (BiPAP) devices, oral appliances, and adaptive servo-ventilators, help maintain open airways and ensure proper breathing throughout sleep. These devices play a crucial role in improving sleep quality, preventing complications, and enhancing overall health.

Market Dynamics:

Driver:

Rising prevalence of sleep apnea

Sleep-disordered breathing affects millions globally and contributes to cardiovascular neurological and metabolic complications. Platforms support early detection symptom monitoring and treatment adherence using CPAP BiPAP and wearable diagnostics. Integration with telehealth AI-based screening and remote monitoring enhances accessibility and clinical outcomes. Demand for scalable and non-invasive solutions is rising across aging populations and high-risk cohorts. These dynamics are propelling platform deployment across sleep medicine and chronic disease management ecosystems.

Restraint:

High cost of therapy and ongoing consumable costs

Devices require upfront investment and recurring expenses for masks tubing and filters that strain patient budgets. Reimbursement gaps and fragmented payer policies further complicate access and affordability. Enterprises face challenges in aligning pricing models with clinical outcomes and patient engagement. Vendors must offer subscription models bundled care and cost-transparent platforms to improve uptake. These constraints continue to hinder platform maturity across low-income and underinsured populations.

Opportunity:

Shift to home-based testing and telehealth

Patients increasingly prefer at-home sleep studies and virtual consultations to avoid clinical wait times and improve convenience. Platforms integrate with mobile apps cloud-based analytics and wearable sensors to deliver real-time insights and personalized therapy. Demand for scalable and privacy-compliant solutions is rising across primary care employer wellness and insurance-backed programs. Vendors offer modular kits AI-driven triage and outcome dashboards to support hybrid care models. These trends are fostering growth across home-centric and digitally enabled sleep apnea ecosystems.

Threat:

Limited awareness & infrastructure in developing markets

Many regions lack trained sleep specialists diagnostic labs and reimbursement frameworks to support widespread screening and treatment. Cultural stigma low health literacy and limited digital access further degrade demand and engagement. Enterprises face challenges in deploying scalable and regionally adapted solutions across rural and peri-urban populations. Vendors must invest in education campaigns mobile-first platforms and public-private partnerships to expand reach. These limitations continue to restrict platform performance across underserved and infrastructure-limited geographies.

Covid-19 Impact:

The pandemic disrupted sleep clinics diagnostic workflows and therapy adherence across global markets. Lockdowns delayed in-lab studies and reduced access to respiratory therapists and sleep specialists. Post-pandemic recovery emphasized remote care digital diagnostics and patient self-management across sleep medicine. Investment in telemonitoring AI screening and home-based therapy surged across healthcare systems and consumer channels. Public awareness of sleep health and its link to immunity and mental well-being increased across policy and clinical circles. These shifts are reinforcing long-term investment in decentralized and digitally enabled sleep apnea infrastructure.

The therapeutic devices segment is expected to be the largest during the forecast period

The therapeutic devices segment is expected to account for the largest market share during the forecast period due to their clinical relevance scalability and widespread adoption across sleep apnea treatment. Platforms include CPAP BiPAP and auto-adjusting devices that support airway management and symptom relief. Integration with humidifiers data tracking and remote monitoring enhances adherence and personalization. Demand for compact quiet and travel-friendly devices is rising across homecare and outpatient settings. Vendors offer modular configurations cloud connectivity and patient engagement tools to support long-term therapy. These capabilities are boosting segment dominance across therapeutic sleep apnea platforms.

The complex sleep apnea syndrome segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the complex sleep apnea syndrome segment is predicted to witness the highest growth rate as diagnostic and therapeutic platforms expand across mixed and treatment-emergent apnea cases. Patients exhibit both obstructive and central apnea patterns requiring advanced monitoring and adaptive therapy. Platforms support multi-channel diagnostics algorithmic titration and integrated care across cardiology neurology and pulmonology. Integration with AI engines wearable sensors and cloud-based analytics enhances precision and responsiveness. Demand for scalable and clinically validated solutions is rising across specialty clinics and tertiary care centers. These dynamics are accelerating growth across complex sleep apnea syndrome platforms and services.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to its healthcare infrastructure reimbursement frameworks and clinical adoption across sleep apnea technologies. Enterprises and providers deploy platforms across hospitals homecare and employer wellness programs to meet rising demand. Investment in AI diagnostics telehealth and therapeutic innovation supports scalability and personalization. Presence of leading vendors academic institutions and policy initiatives drives ecosystem maturity and adoption. Firms align sleep apnea strategies with chronic disease management value-based care and digital health goals.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR as urbanization healthcare modernization and sleep disorder awareness converge across regional economies. Countries like China India Japan and South Korea scale platforms across public health employer wellness and consumer channels. Government-backed programs support infrastructure development digital health adoption and awareness campaigns across sleep medicine. Local providers offer cost-effective culturally adapted and mobile-first solutions tailored to regional needs. Demand for scalable and inclusive sleep apnea infrastructure is rising across urban and peri-urban markets. These trends are accelerating regional growth across sleep apnea innovation and deployment.

Key players in the market

Some of the key players in Sleep Apnea Diagnostic and Therapeutic Devices Market include ResMed Inc., Koninklijke Philips N.V., Fisher & Paykel Healthcare Corporation Limited, Drive DeVilbiss Healthcare LLC, Compumedics Limited, BMC Medical Co. Ltd., SomnoMed Limited, Natus Medical Incorporated, Itamar Medical Ltd., Braebon Medical Corporation, Curative Medical Inc., Lowenstein Medical Technology GmbH + Co. KG, Cadwell Industries Inc., Cleveland Medical Devices Inc. and AirAvant Medical Inc.

Key Developments:

In October 2025, ResMed entered a joint venture with Google's Verily, aiming to develop software solutions for diagnosing and managing sleep apnea and related breathing disorders. The U.S.-based venture combined ResMed's clinical expertise with Verily's data analytics capabilities to improve early detection and personalized treatment pathways for millions of undiagnosed patients.

In May 2025, - Philips acquired DiA Imaging Analysis, an AI-powered ultrasound software firm, to strengthen its diagnostic imaging capabilities. While not exclusive to sleep apnea, the acquisition supported Philips' broader strategy to integrate AI into multi-modality diagnostics, including respiratory and sleep-related imaging workflows.

Product Types Covered:

  • Diagnostic Devices
  • Therapeutic Devices
  • Accessories & Consumables

Technologies Covered:

  • Diagnostic Technologies
  • Therapeutic Technologies

Distribution Channels Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Platforms
  • Direct Sales

Applications Covered:

  • Obstructive Sleep Apnea (OSA)
  • Central Sleep Apnea (CSA)
  • Complex Sleep Apnea Syndrome
  • Other Applications

End Users Covered:

  • Hospitals
  • Sleep Clinics
  • Homecare Settings
  • Research & Academic Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Sleep Apnea Diagnostic and Therapeutic Devices Market, By Product Type

  • 5.1 Introduction
  • 5.2 Diagnostic Devices
  • 5.3 Therapeutic Devices
  • 5.4 Accessories & Consumables

6 Global Sleep Apnea Diagnostic and Therapeutic Devices Market, By Technology

  • 6.1 Introduction
  • 6.2 Diagnostic Technologies
    • 6.2.1 Polysomnography (PSG) Systems
    • 6.2.2 Respiratory Polygraphs
    • 6.2.3 Pulse Oximeters
    • 6.2.4 Actigraphy Devices
    • 6.2.5 AI-Enabled Sleep Monitoring
    • 6.2.6 Cloud-Based Data Analytics
  • 6.3 Therapeutic Technologies
    • 6.3.1 Positive Airway Pressure (PAP) Devices
    • 6.3.2 Oral Appliances
    • 6.3.3 Adaptive Servo-Ventilation (ASV)
    • 6.3.4 Smart Masks & Accessories
    • 6.3.5 Humidifiers and Comfort Devices
    • 6.3.6 Telemonitoring and Connected Therapy Systems

7 Global Sleep Apnea Diagnostic and Therapeutic Devices Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Hospital Pharmacies
  • 7.3 Retail Pharmacies
  • 7.4 Online Platforms
  • 7.5 Direct Sales

8 Global Sleep Apnea Diagnostic and Therapeutic Devices Market, By Application

  • 8.1 Introduction
  • 8.2 Obstructive Sleep Apnea (OSA)
  • 8.3 Central Sleep Apnea (CSA)
  • 8.4 Complex Sleep Apnea Syndrome
  • 8.5 Other Applications

9 Global Sleep Apnea Diagnostic and Therapeutic Devices Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Sleep Clinics
  • 9.4 Homecare Settings
  • 9.5 Research & Academic Institutions
  • 9.6 Other End Users

10 Global Sleep Apnea Diagnostic and Therapeutic Devices Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 ResMed Inc.
  • 12.2 Koninklijke Philips N.V.
  • 12.3 Fisher & Paykel Healthcare Corporation Limited
  • 12.4 Drive DeVilbiss Healthcare LLC
  • 12.5 Compumedics Limited
  • 12.6 BMC Medical Co. Ltd.
  • 12.7 SomnoMed Limited
  • 12.8 Natus Medical Incorporated
  • 12.9 Itamar Medical Ltd.
  • 12.10 Braebon Medical Corporation
  • 12.11 Curative Medical Inc.
  • 12.12 Lowenstein Medical Technology GmbH + Co. KG
  • 12.13 Cadwell Industries Inc.
  • 12.14 Cleveland Medical Devices Inc.
  • 12.15 AirAvant Medical Inc.

List of Tables

  • Table 1 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Diagnostic Devices (2024-2032) ($MN)
  • Table 4 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Therapeutic Devices (2024-2032) ($MN)
  • Table 5 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Accessories & Consumables (2024-2032) ($MN)
  • Table 6 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Technology (2024-2032) ($MN)
  • Table 7 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Diagnostic Technologies (2024-2032) ($MN)
  • Table 8 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Polysomnography (PSG) Systems (2024-2032) ($MN)
  • Table 9 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Respiratory Polygraphs (2024-2032) ($MN)
  • Table 10 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Pulse Oximeters (2024-2032) ($MN)
  • Table 11 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Actigraphy Devices (2024-2032) ($MN)
  • Table 12 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By AI-Enabled Sleep Monitoring (2024-2032) ($MN)
  • Table 13 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Cloud-Based Data Analytics (2024-2032) ($MN)
  • Table 14 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Therapeutic Technologies (2024-2032) ($MN)
  • Table 15 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Positive Airway Pressure (PAP) Devices (2024-2032) ($MN)
  • Table 16 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Oral Appliances (2024-2032) ($MN)
  • Table 17 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Adaptive Servo-Ventilation (ASV) (2024-2032) ($MN)
  • Table 18 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Smart Masks & Accessories (2024-2032) ($MN)
  • Table 19 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Humidifiers and Comfort Devices (2024-2032) ($MN)
  • Table 20 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Telemonitoring and Connected Therapy Systems (2024-2032) ($MN)
  • Table 21 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 22 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 23 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 24 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 25 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 26 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Application (2024-2032) ($MN)
  • Table 27 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Obstructive Sleep Apnea (OSA) (2024-2032) ($MN)
  • Table 28 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Central Sleep Apnea (CSA) (2024-2032) ($MN)
  • Table 29 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Complex Sleep Apnea Syndrome (2024-2032) ($MN)
  • Table 30 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 31 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By End User (2024-2032) ($MN)
  • Table 32 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 33 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Sleep Clinics (2024-2032) ($MN)
  • Table 34 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Homecare Settings (2024-2032) ($MN)
  • Table 35 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Research & Academic Institutions (2024-2032) ($MN)
  • Table 36 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.